A Midwest pharmaceutical company manufactures individual syringes with a self contained, single dose of an injectable drug. 7 In the manufacturing process, sterile liquid drug is poured into glass syringes and sealed with a rubber stopper. The remaining stage involves insertion of the cartridge into plastic syringes and the electrical “ tacking” of the containment cap at a precisely determined length of the syringe. A cap that is tacked at a shorter than desired length (less than 4.920 inches) leads to pressure on the cartridge stopper and, hence, partial or complete activation of the syringe. Such syringes must then be scrapped. If the cap is tacked at a longer than desired length (4.980 inches or longer), the tacking is incomplete or inadequate, which can lead to cap loss and a potential cartridge loss in shipment and handling. Such syringes can be reworked manually to attach the cap at a lower position. However, this process requires a 100% inspection of the tacked syringes and results in increased cost for the items. This final production step seemed to be producing more and more scrap and reworked syringes over successive weeks. The Excel file Syringe Samples provides samples taken every 15 minutes from the manufacturing process. Develop control limits using the data and use statistical thinking ideas to draw conclusions.